Study the topical effect of six days use of different lycopene doses on imiquimod-induce psoriasis-like skin inflammation in Mice

Samer Shukur Mohammed; Haitham Mahmood Kadhim; Israa Mahdi Al-Sudani; Wael Waleed Musatafa

doi:10.53730/ijhs.v6nS3.5241

Authors

Samer Shukur Mohammed
samer.shukur@ruc.edu.iq
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Rafidain University College, 10052 Baghdad, Iraq
Haitham Mahmood Kadhim Department of Pharmacology, College of Pharmacy, Al-Nahrain University, Baghdad, Iraq
Israa Mahdi Al-Sudani Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
Wael Waleed Musatafa Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Rafidain University College, 10052 Baghdad, Iraq

Keywords:

imiquimod-induce, inflammation, lycopene doses, psoriasis-like skin, topical effect

Abstract

Lycopene is a hydrocarbon phytochemical that is present in red vegetables and fruits, several studies reviewed the pharmacological properties of Lycopene across years ago and in different aspects including inflammation, cardiovascular disease, prostatic cancer and different dermatological complaints. Objective: we investigated the potential impact of two different doses of topical Lycopene and as add on therapy to Clobetasol on Psoriasis model that induced by Imiquimod in mice. Methods: This was accomplished by dividing 48 mice into six groups (8 mice per each group). All groups received Imiquimod for induction of Psoriasis (except Group I which is healthy group) across the experiment days. Group II (Induction group) received Petrolatum gel (Vaseline) for six days after 6 days induction period with Imiquimod. The rest groups III, IV,V,VI received Clobetasol propionate 0.05%, 0.125 mg/ml Lycopene, 0.25 mg/ml Lycopene and combination of 0.25 mg/ml Lycopene and 0.05% Clobetasol propionate ointments respectively once daily for six days after 6 days of induction period with Imiquimod.

Downloads

Download data is not yet available.

References

Nestle, F.O.; Kaplan, D.H.; Barker, J. Psoriasis. N. Engl. J. Med. 2009, 361, 496–509

z, J.C. The role of T cells in psoriasis. J. Eur. Acad. Dermatol. Venereol. 2003, 17, 257–270

Pariser, D., Schenkel, B., Carter, C., Farahi, K., Brown, T. M., Ellis, C. N. & Group, P. P. I. S.. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. Journal of Dermatological Treatment 2016, 27, 19-26

Griffiths, C.E. and Barker, J.N. Pathogenesis and clinical features of psoriasis. The Lancet 2007, 370(9583),pp.263-271.

Bachelez, H., Van de Kerkhof, P.C., Strohal, R., Kubanov, A., Valenzuela, F., Lee, J.H., Yakusevich, V., Chimenti, S., Papacharalambous, J., Proulx, J. and Gupta, P. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. The Lancet (2015), 386(9993), pp.552561.

Van der Fits, L., Mourits, S., Voerman, J.S., Kant, M., Boon, L., Laman, J.D., Cornelissen, F., Mus, A.M., Florencia, E., Prens, E.P. and Lubberts, E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. The Journal of Immunology (2009), 182(9), pp.5836-5845

Moorchung, N., Kulaar, J.S., Chatterjee, M., Vasudevan, B., Tripathi, T., Dutta, V. Role of NF-κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. Int. J. Dermatol. (2014) 53, 570- 574

Hwang, E.S.; Lee, H.J. Inhibitory e_ects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Exp. Biol. Med. (Maywood) 2006, 231, 322–327

Gajendragadkar, P.R.; Hubsch, A.; Maki-Petaja, K.M.; Serg, M.; Wilkinson, I.B.; Cheriyan, J. Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: A randomised controlled trial. PLoS ONE. 2014, 9, e99070

Kim, J.Y.; Paik, J.K.; Kim, O.Y.; Park, H.W.; Lee, J.H.; Jang, Y.; Lee, J.H. E_ects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 2011, 215, 189–195

Yang, P.M.; Chen, H.Z.; Huang, Y.T.; Hsieh, C.W.; Wung, B.S. Lycopene inhibits NF-kappaB activation and adhesion molecule expression through Nrf2-mediated heme oxygenase-1 in endothelial cells. Int. J. Mol. Med. 2017, 39, 1533–1540

Chen, P.; Xu, S.; Qu, J. Lycopene Protects Keratinocytes Against UVB Radiation-Induced Carcinogenesis via Negative Regulation of FOXO3a Through the mTORC2/AKT Signaling Pathway. J. Cell Biochem. 2018, 119, 366–377.

Allen, L. V., & Ansel, H. C. Ansel's pharmaceutical dosage forms and drug delivery systems (10th edition), 2014. Wolters Kluwer Health business. Page 274-276

Sun J, Zhao Y, Hu J. Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice. PLoS ONE,2013, 8(6): e67078

Shih CM, Hsieh CK, Huang CY, et al. Lycopene Inhibit IMQ-Induced Psoriasis-Like Inflammation by Inhibiting ICAM-1 Production in Mice. Polymers (Basel). 2020;12(7):1521.

Parasuraman, S., Raveendran, R., & Kesavan, R. Blood sample collection in small laboratory animals. Journal of pharmacology & pharmacotherapeutics, 2010;1(2), 87–93

Arora, N., Shah, K. & Pandey-Rai, S. Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants. Protoplasma,2016; 253, 503-515.

Chen, H., Lu, C., Liu, H., Wang, M., Zhao, H., Yan, Y. and Han, L. Quercetin ameliorates imiquimodinduced psoriasis-like skin inflammation in mice via the NF-κB pathway. International immunopharmacology,2017; 48,pp.110-117.

Baek, J.O., Byamba, D., Wu, W.H., Kim, T.G. and Lee, M.G. Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress. Archives of dermatological research,2012; 304(9), pp.699-706

Cardiff, R. D., Miller, C. H. & Munn, R. J. 2014. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harbor protocols,1-5.

Bancroft J.D, Layton C.,Suvarna S.K, Bancroft's Theory and Practice of Histological Techniques (Seventh Edition),2013;Churchill Livingstone, Pages 173-186.

Luo L, Kang D, Li B, Jiang W, Lu Q, Rong M, Lai R. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie.2016; ;123:73-80

Baker BS, Fry L . The immunology of psoriasis. Br J Dermatol.1992;126(1):1-9

Harper, E.G., Guo, C., Rizzo, H., Lillis, J.V., Kurtz, S.E., Skorcheva, I., Purdy, D., Fitch, E., Iordanov, M. and Blauvelt, A. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. Journal of Investigative Dermatology,2009; 129(9), pp.2175-2183.

Caldarola, G., De Simone, C., Carbone, A., Tulli, A., Amerio, P. and Feliciani, C. TNFa and its receptors in psoriatic skin, before and after treatment with Etanercept. International journal of immunopathology and pharmacology,2009; 22(4), pp.961-966.

Bugaut, H. and S. Aractingi. "Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies." Frontiers in Immunology,2021; 12: 106.

Abdou AG, Hanout HM. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. J Cutan Pathol. 2008;35(5):445-451.

Peacock Janet L. and Peacock Philip J. 2011. Oxford handbook of medical statistics. Ch .8,pp 237 : Oxford university press.

Glitzner, E.; Korosec, A.; Brunner, P. M.; Drobits, B.; Amberg, N.; Schonthaler, H. B.; Kopp, T.; Wagner, E. F.; Stingl, G.; Holcmann, M.; Sibilia, M.. Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Molecular Medicine,2014; 6(10), 1312–1327.

Chen, H., Lu, C., Liu, H. et al.Quercetin ameliorates imiquimod induced psoriasis-like skin inflammation in mice via the NF-κB pathway. International immunopharmacology,2017; 48, pp.110-117.

Na Takuathung, M., Wongnoppavich, A., Panthong, A., Khonsung, P., Chiranthanut, N., Soonthornchareonnon, N. and Sireeratawong, S. Antipsoriatic effects of wannachawee recipe on imiquimodinduced psoriasis-like dermatitis in BALB/cMice. Evidence-Based Complementary and Alternative Medicine, 2018.

Redegeld, F. A., Yu, Y., Kumari, S., Charles, N. & Blank, U. Non- IgE mediated mast cell activation. Immunological reviews,2018; 282, 87-113.

Zeichner, J. A. & Armstrong, A.The role of IL-17 in the pathogenesis and treatment of psoriasis. The Journal of clinical and aesthetic dermatology,2016;9, 3-9.

Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis Prevalence in Adults in the United States . JAMA Dermatol.,2021; 157(8):940–946

Takahashi, H., Tsuji, H., Honma, M., Ishida-Yamamoto, A. & Iizuka, H. Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis. Archives of dermatological research,2013; 305, 113116.

Van De Kerkhof, P. C. An update on topical therapies for mild moderate psoriasis. Dermatologic clinics,2015; 33,73-77

Adcock, I.M. and Lane, S.J. Mechanisms of steroid action and resistance in inflammation. Corticosteroid-insensitive asthma: molecular mechanisms. Journal of Endocrinology,2003; 178(3), pp.347-355

Griffiths, C.E. and Barker, J.N. Pathogenesis and clinical features of psoriasis. The Lancet,2007; 370(9583), pp.263-271

Kwatra, G. & Mukhopadhyay, S. Topical corticosteroids: Pharmacology.A treatise on topical corticosteroids in dermatology. International Journal of Pharmacy & Life Science,2018;2,857-877.

Schoepe, S., Schäcke, H., May, E. and Asadullah, K. Glucocorticoid therapy-induced skin atrophy. Experimental dermatology,2006; 15(6), pp.406-420.

Norman I., Elizabeth J., Carotenoid actions and their relation to health and disease.Molecular Aspects of Medicine,2005;.26(6):459-516.

Zsuzsanna F., Dayuan G., Saladi R. et al., Protective Effects of Lycopene Against Ultraviolet B-Induced Photodamage, Nutrition and Cancer ,2003; 47:2, 181-187

Hiragun M, Hiragun T, Oseto I, et al. Oral administration of β-carotene or lycopene prevents atopic dermatitis-like dermatitis in HR-1 mice. J Dermatol.,2016;43(10):1188-1192.

Hugh, J.M. and Weinberg, J.M.Update on the pathophysiology of psoriasis. Cutis,2018; 102(5S), pp.6-12

Sun, S., Cao, C., Li, J., Meng, Q., Cheng, B., Shi, B., & Shan, A. Lycopene Modulates Placental Health and Fetal Development Under High‐Fat Diet During Pregnancy of Rats. Molecular Nutrition & Food Research,2021; 65(14), 2001148.

Yang PM, Chen HZ, Huang YT, Hsieh CW, Wung BS. Lycopene inhibits NF-κB activation and adhesion molecule expression through Nrf2-mediated heme oxygenase-1 in endothelial cells. Int J Mol Med. 2017;39(6):1533-1450.

Elmets CA, Korman NJ, Prater EF et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures .Journal of the American Academy of Dermatology,2020 .